Moderate Weight Loss Reduces Renin and Aldosterone but does not Influence Basal or Stimulated Pituitary-adrenal Axis Function

Abstract

Body fat mass and nutrition influence secretion of the adrenocortical hormones - aldosterone and cortisol - via several mechanisms. However, there are no data on adrenocortical function following widely prescribed mild diet-induced weight loss (10%) in obese subjects. In the present study, 25 healthy obese volunteers (BMI 32.9±4.3 kg/m²) followed a 30% calorie restricted diet over 12 weeks. Hypothalamic-pituitary-adrenal (HPA) axis function was assessed by 24-hour urine free cortisol/cortisone and a 1 mcg ACTH stimulation test with measurement of total and free cortisol and corticosteroid-binding globulin (CBG). The renin-angiotensin-aldosterone system (RAAS) was assessed by measurement of plasma aldosterone and renin under salt depleted (30 mmol/d) and loading (250 mmol/d) conditions. Volunteers’ weight fell by 8.5±0.8 kg (8.9±0.7%) and seated systolic blood pressure fell by 8.7±2.7 mm Hg and diastolic blood pressure by 7.0±1.4 mmHg (p<0.01). Plasma aldosterone and renin levels fell significantly with weight loss (aldosterone: 853±156-635±73 pmol/l; renin: 35.4±7-24±3 mU/l, both p<0.05). The volunteers were relatively salt insensitive (mean arterial pressure change with salt intake: 4 mmHg) and this was not affected by weight loss. Moderate weight loss had no effect on 24-hour urine free cortisol/cortisone, or on basal, or ACTH-stimulated free and total cortisol, or CBG. Hence this conventional weight loss program reduces blood pressure and activity of the RAAS via an effect on renin release. Despite various described influences of fat mass and energy restriction on HPA axis function, there were no changes in basal and stimulated HPA axis function with moderate weight loss. There may be a threshold effect of weight loss/energy restriction required to alter HPA axis function, or moderate weight loss may lead to a counterbalanced effect of stimulatory and inhibitory influences on HPA axis function.

Key words

Obesity - blood pressure - weight loss - aldosterone - cortisol

References

• 1 Kannel WB, Garrison RJ, Dannenberg AL. Secular blood pressure trends in normotensive persons: the Framingham Study.  Am Heart J. 1993;  125 1154-1158
• 2 Aucott L, Poobalan A, Smith WC, Avenell A, Jung R, Broom J. Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review.  Hypertension. 2005;  45 1035-1041
• 3 Berchtold P, Sims EA, Horton ES, Berger M. Obesity and hypertension: epidemiology, mechanisms, treatment.  Biomed Pharmacother. 1983;  37 251-258
• 4 Dornfeld LP, Maxwell MH, Waks A, Tuck M. Mechanisms of hypertension in obesity.  Kidney Int Suppl. 1987;  22 S254-S258
• 5 El Atat F, Aneja A, Macfarlane S, Sowers J. Obesity and hypertension.  Endocrinol Metab Clin North Am. 2003;  32 823-854
• 6 Rocchini AP. Obesity hypertension.  Am J Hypertens. 2002;  15 ((2 Pt 2)) 50S-52S
• 7 Douyon L, Schteingart DE. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion.  Endocrinol Metab Clin North Am. 2002;  31 173-189
• 8 Rocchini AP, Moorehead C, DeRemer S, Goodfriend TL, Ball DL. Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II.  Hypertension. 1990;  15 ((6 Pt 2)) 861-866
• 9 Hiramatsu K, Yamada T, Ichikawa K, Izumiyama T, Nagata H. Changes in endocrine activities relative to obesity in patients with essential hypertension.  J Am Geriatr Soc. 1981;  29 25-30
• 10 Lamounier-Zepter V, Rotthoff T, Ansurudeen I, Kopprasch S, Scherbaum WA, Ehrhart-Bornstein M. et al . Increased aldosterone/renin quotient in obese hypertensive women: a novel role for low-density lipoproteins?.  Horm Metab Res. 2006;  38 471-475
• 11 Goodfriend TL, Egan BM, Kelley DE. Aldosterone in obesity.  Endocr Res. 1998;  24 ((3-4)) 789-796
• 12 Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A. et al . Human adipocytes secrete mineralocorticoid-releasing factors.  Proc Natl Acad Sci USA. 2003;  100 14211-14216
• 13 Schinner S, Willenberg HS, Krause D, Schott M, Lamounier-Zepter V, Krug AW. et al . Adipocyte-derived products induce the transcription of the StAR promoter and stimulate aldosterone and cortisol secretion from adrenocortical cells through the Wnt-signaling pathway.  Int J Obes (Lond). 2007;  31(5) 864-870
• 14 Krug A, Vleugels K, Schinner S, Lamounier-Zepter V, Ziegler CG, Bornstein SR. et al . Human Adipocytes Induce an ERK1/2 MAPkinases - mediated Upregulation of Steroidogenic Acute Regulatory Protein (StAR) and an Angiotensin II - Sensitization in Human Adrenocortical Cells.  Int J Obes. 2007;  , in press
• 15 Marin P, Darin N, Amemiya T, Andersson B, Jern S, Bjorntorp P. Cortisol secretion in relation to body fat distribution in obese premenopausal women.  Metabolism. 1992;  41 882-886
• 16 Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R. et al . The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution.  J Clin Endocrinol Metab. 1993;  77 341-346
• 17 Rosmond R, Dallman MF, Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities.  J Clin Endocrinol Metab. 1998;  83 1853-1859
• 18 Fernandez-Real JM, Pugeat M, Grasa M, Broch M, Vendrell J, Brun J. et al . Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study.  J Clin Endocrinol Metab. 2002;  87 4686-4690
• 19 Tomlinson JW, Moore JS, Clark PM, Holder G, Shakespeare L, Stewart PM. Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue.  J Clin Endocrinol Metab. 2004;  89 2711-2716
• 20 Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V. et al . The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents.  N Engl J Med. 1989;  321 580-585
• 21 Yanovski JA, Yanovski SZ, Gold PW, Chrousos GP. Differences in corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol before and after weight loss.  J Clin Endocrinol Metab. 1997;  82 1874-1878
• 22 Vertes V, Genuth SM, Hazelton IM. Supplemented fasting as a large-scale outpatient program.  JAMA. 1977;  238 2151-2153
• 23 Mattson MP, Wan R. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems.  J Nutr Biochem. 2005;  16 129-137
• 24 Ho JT, Al Musalhi H, Chapman MJ, Quach T, Thomas PD, Bagley CJ. et al . Septic shock and sepsis: a comparison of total and free plasma cortisol levels.  J Clin Endocrinol Metab. 2006;  91 105-114
• 25 Lewis JG, Lewis MG, Elder PA. An enzyme-linked immunosorbent assay for corticosteroid-binding globulin using monoclonal and polyclonal antibodies: decline in CBG following synthetic ACTH.  Clin Chim Acta. 2003;  328 ((1-2)) 121-128
• 26 Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M. et al . Weight loss and the renin-angiotensin-aldosterone system.  Hypertension. 2005;  45 356-362
• 27 Landsberg L, Krieger DR. Obesity, metabolism, and the sympathetic nervous system.  Am J Hypertens. 1989;  2 ((3 Pt 2)) 125S-132S
• 28 Weinberger MH. Salt sensitivity of blood pressure in humans.  Hypertension. 1996;  27 ((3 pt 2)) 481-490
• 29 Midley JP, Matthew G, Greenwood CMT, Logan AG. Effects of reduced dietary salt on blood pressure: A meta analysis of randomised controlled trials.  J Amer Med Assoc. 1996;  275 1590-1597
• 30 He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure.  Cochrane Database Syst Rev. 2004;  ((3)) CD004937
• 31 Sullivan JM. Salt sensitivity. Definition, conception, methodology, and long term issues.  Hypertension. 1991 Jan;  17 ((1 Suppl)) I61-I68

Correspondence